Although these inhibitors have shown minimal benefits for asthma in clinical trials, knocking-out all of the NOS isoforms decreases airway inflammation and reduces Th2 cytokines such as IL-4, IL-5, and IL-13 in asthmatic mice [24]. The gene discussed is IL13; the disease is asthma.